section name header
Index
Administration
Antiplatelet Agents for Intermittent Claudication
Antiplatelet Agents for Preventing Thrombosis after Peripheral Arterial Bypass Surgery
Antiplatelet Drugs for Prevention of Restenosis after Peripheral Endovascular Treatment
Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke
Antithrombotic Agents in Primary Health Care - Related Resources
Aspirin Resistance and Risk of Cardiovascular Morbidity
Cardiology
Cardiovascular diseases
Clinical pharmacology
Clopidogrel and Aspirin in Acute ST-Segment Elevation Myocardial Infarction (STEMI)
Clopidogrel Plus Aspirin Versus Aspirin Alone for Preventing Cardiovascular Disease in Acute Non-ST Segment Coronary Syndromes
Clopidogrel Plus Aspirin Vs Aspirin Alone for Preventing Cardiovascular Events
Cochrane review
Evidence summary
Female
Internal medicine
Medical Treatment to Increase Patency of Arteriovenous Fistulae and Grafts
Neurology
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
Oral Anticoagulants Vs Antiplatelet Therapy for Preventing Stroke in Patients with Non-Valvular Atrial Fibrillation and No History of Stroke or TIA
Pharmacology
Platelet Glycoprotein Iib/Iiia Receptor Antagonists in Cardiovascular Disease
Routine or Selective Invasive Strategy for Acute Coronary Syndrome
Stem Cell Therapy for Chronic Ischaemic Heart Disease and Congestive Heart Failure
Systematic review
Thienopyridine Derivatives (Ticlopidine, Clopidogrel) Versus Aspirin or Aspirin-Dipyridamole for Preventing Serious Vascular Events in High Risk Patients
Warfarin or Antiplatelet Therapy for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation